A unicorn joins this week’s stampede of biotechs into the red-hot Nasdaq casino

Now that the July 4 holiday week is well behind us, Nasdaq is getting cracking again with new offerings, and biotech companies — including a Flagship-built unicorn — are once again dominating the latest round of IPOs lining up for their Nasdaq closeup this week.